Eagle Asset Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-269,558
| Closed | -$8.22M | – | 598 |
|
|
2023
Q4 | $8.22M | Buy |
269,558
+26,867
| +11% | +$819K | 0.04% | 303 |
|
|
2023
Q3 | $7.67M | Buy |
242,691
+7,462
| +3% | +$236K | 0.05% | 298 |
|
|
2023
Q2 | $9.59M | Buy |
235,229
+63,350
| +37% | +$2.58M | 0.05% | 269 |
|
|
2023
Q1 | $6.41M | Sell |
171,879
-15,486
| -8% | -$577K | 0.04% | 312 |
|
|
2022
Q4 | $6.49M | Sell |
187,365
-7,698
| -4% | -$267K | 0.04% | 295 |
|
|
2022
Q3 | $10.9M | Sell |
195,063
-3,969
| -2% | -$222K | 0.07% | 229 |
|
|
2022
Q2 | $10.3M | Sell |
199,032
-32,485
| -14% | -$1.68M | 0.06% | 240 |
|
|
2022
Q1 | $16.8M | Buy |
231,517
+10,113
| +5% | +$735K | 0.09% | 212 |
|
|
2021
Q4 | $26.8M | Sell |
221,404
-9,908
| -4% | -$1.2M | 0.12% | 191 |
|
|
2021
Q3 | $31M | Sell |
231,312
-34,811
| -13% | -$4.67M | 0.14% | 183 |
|
|
2021
Q2 | $43.1M | Buy |
+266,123
| New | +$43.1M | 0.19% | 167 |
|